BioCentury This Week

A Science podcast by BioCentury

5.0 • 9 ratings

Want connect with BioCentury and email directly about potential partnerships?

BioCentury's streaming commentary on biotech industry trends, plus interviews with leading KOLs. For over 28 years, BioCentury has given biopharma executives, investors and institutions the power to make business-critical decisions through independent, deep-dive analysis; high-quality data; industry-leading business intelligence; and global conferences.

Recent Episodes

Ep. 227 - Defending Accelerated Approval. Plus: Endpoint Innovation & AIM Amiss
Published: April 22, 2024
Listen
Ep. 226 - Vertex’s Alpine Buy, Goldman’s Venture & IRA Tea Leaves
Published: April 16, 2024
Listen
Ep. 225 - 2Q Markets Preview & AACR Takeaways
Published: April 8, 2024
Listen
Ep. 224 - Biotech IPOs, Avalon & FDA at SCOTUS
Published: April 2, 2024
Listen
Ep. 223 - Biosecure, Bruce Booth & Ultrarare Drugs
Published: March 26, 2024
Listen
Ep. 222 - Crowley’s Vision for BIO, Plus: MASH & CAR Ts
Published: March 18, 2024
Listen
Ep. 221 - China Biocontroversy, Plus: Diversity Matters
Published: March 12, 2024
Listen
Ep. 220 - Biotech’s Financing Flurry & Distillery Spotlight
Published: March 5, 2024
Listen
Ep. 219 - East-West Summit Preview
Published: February 28, 2024
Listen
Ep. 218 - Bob Nelsen Insights, TL1A, Rare Diseases
Published: February 27, 2024
Listen

Listen to All Episodes From BioCentury This Week